Ropes & Gray represented Taconic Biosciences, Inc., a portfolio company of Avista Healthcare Partners, in its acquisition of TransCure bioServices SAS, a provider of preclinical research services utilizing humanized immune system (HIS) mouse models. The transaction was announced on January 20.
Taconic Biosciences is a global provider of genetically engineered rodent models and HIS mice, providing essential tools for immuno-oncology, immunology, neuroscience, and metabolic disease research.
The Ropes & Gray Team was led in New York and Paris by private equity partners Emmanuel Mimin and Bob Rivollier, with support from private equity counsel Raphaël Durand, and associates Julie Brissy and Matthew Kaczor. This team also included life sciences partner Lincoln Tsang.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.